AhR activation mitigates graft-versus-host disease of the central nervous system by reducing microglial NF-κB signaling.
Zähringer A, Morgado I, Erny D, Ingelfinger F, Gawron J, Chatterjee S, Wenger V, Schmidt D, Schwöbel L, Adams RC, Langenbach M, Hartmann A, Osswald N, Wolf J, Schlunck G, Briquez PS, Grueter K, Ruess DA, Frew I, Burk AC, Holzmüller V, Grimbacher B, Michonneau D, Andrieux G, Socié G, Kolter J, Boerries M, Follo M, Blaeschke F, Sevenich L, Prinz M, Zeiser R, Vinnakota JM.
Zähringer A, et al. Among authors: ruess da.
Blood Adv. 2025 Jun 24;9(12):2935-2952. doi: 10.1182/bloodadvances.2024015000.
Blood Adv. 2025.
PMID: 40163754
Free PMC article.